Edition:
United States

Magellan Health Inc (MGLN.OQ)

MGLN.OQ on NASDAQ Stock Exchange Global Select Market

66.95USD
4:00pm EDT
Change (% chg)

$0.50 (+0.75%)
Prev Close
$66.45
Open
$66.25
Day's High
$67.10
Day's Low
$65.35
Volume
50,004
Avg. Vol
75,793
52-wk High
$82.00
52-wk Low
$49.65

Latest Key Developments (Source: Significant Developments)

Magellan Health reports Q4 earnings per share $1.50
Friday, 24 Feb 2017 06:30am EST 

Magellan Health Inc : Magellan Health reports fourth quarter 2016 and full year financial results . Qtrly adjusted earnings per share $ 1.80 . Reiterating its 2017 guidance . Qtrly earnings per share $1.50 . Qtrly net revenue $1,263.4 million versus $1,268.7 million . Q4 earnings per share view $1.37, revenue view $1.33 billion -- Thomson Reuters I/B/E/S . Qtrly net revenue $1,263.4 million , down -0.4% . FY2017 earnings per share view $4.30 -- Thomson Reuters I/B/E/S . FY2017 revenue view $5.90 billion -- Thomson Reuters I/B/E/S . Magellan Health - based on updated estimate of average fully diluted shares of 24.2 million, revising 2017 EPS range to between $3.72 and $4.71 per share .Magellan Health - Based on updated estimate of average fully diluted shares of 24.2 million, revising 2017 adjusted EPS to between $5.08 and $5.99 per share.  Full Article

Magellan Health provides 2017 financial guidance
Tuesday, 22 Nov 2016 06:30am EST 

Magellan Health Inc : Sees FY 2017 revenue $5.8 billion to $6.1 billion . Magellan Health Inc - expects cash flow from operations in range of $186 million to $220 million in 2017 . Magellan Health Inc - with respect to 2016, company confirmed its guidance . Magellan Health Inc - veridicus acquisition is estimated to generate net revenues of approximately $220 million and segment profit of $9 million during 2017 . Magellan Health Inc - expect 2017 impact of veridicus to be dilutive by 11 cents on eps and accretive by 12 cents on adjusted eps . Sees FY 2017 adjusted earnings per share $5.19 to $6.12 . Fy2017 earnings per share view $3.60, revenue view $5.23 billion -- Thomson Reuters I/B/E/S . Fy2016 earnings per share view $2.89, revenue view $4.89 billion -- Thomson Reuters I/B/E/S . Magellan Health provides 2017 financial guidance .Sees FY 2017 earnings per share $3.80 to $4.81.  Full Article

Magellan Health to acquire Veridicus Holdings
Monday, 21 Nov 2016 06:30am EST 

Magellan Health Inc - : Magellan Health to acquire Veridicus Holdings, Llc . Deal for $74.5 million . Purchase price is $74.5 million to be paid at closing . Closing of transaction is expected before end of year and is not subject to Hart-Scott-Rodino Ac .Magellan health to acquire Veridicus Holdings, Llc.  Full Article

Magellan Health reports third quarter 2016 financial results
Wednesday, 9 Nov 2016 06:30am EST 

Magellan Health Inc : Magellan Health reports third quarter 2016 financial results . Magellan Health says raises 2016 guidance . Fy2016 earnings per share view $2.38, revenue view $4.77 billion -- Thomson Reuters I/B/E/S . Sees fy 2016 earnings per share $2.86 to $3.24 . Sees fy 2016 revenue $4.78 billion to $5.02 billion . Magellan Health says now expect revenue to be in range of $4.78 to $ 5.02 billion for 2016 . Magellan Health says as compared to updated segment profit guidance range for 2016, currently expect that "solid segment profit growth in 2017" . Q3 earnings per share $1.06 . Q3 revenue $1.3 billion versus I/B/E/S view $1.22 billion .Q3 earnings per share view $0.67 -- Thomson Reuters I/B/E/S.  Full Article

Magellan Health Q2 adjusted EPS $0.58
Friday, 29 Jul 2016 06:30am EDT 

Magellan Health Inc : Revising 2016 guidance for cash flow from operations to a range of $104 million to $135 million, due to acquisition of afsc . Magellan health reports second quarter 2016 financial results . Q2 earnings per share $0.16 . Q2 revenue $1.16 billion versus I/B/E/S view $1.15 billion . Q2 earnings per share view $0.62 -- Thomson Reuters I/B/E/S . Sees 2016 adjusted earnings per share $3.45 to $4.22 . Sees 2016 earnings per share $1.99 to $2.77 . Now expect fy 2016 revenue to be in range of $4.76 to $5.00 billion . "compared to first half of 2016, we expect second half of year to produce stronger segment profit" .Fy2016 earnings per share view $2.84, revenue view $4.72 billion -- Thomson Reuters I/B/E/S.  Full Article

Magellan Health Inc enters into share purchase agreement with Armed Forces Services Corp
Monday, 16 May 2016 06:28am EDT 

Magellan Health Inc : Entered into a share purchase agreement with armed forces services corporation . Deal for cash purchase price at closing equal to $117.5 million, subject to adjustment - SEC filing . Deal includes potential contingent payments up to a maximum aggregate amount of $10.0 million payable after closing of transaction . Certain "key" members of AFSC's management will reinvest a portion of their proceeds in Magellan restricted common stock .Agreement provides for co, unit's purchase from Armed Forces Services Corp of all of outstanding equity interests in AFSC.  Full Article

Magellan Health Inc gives FY 2016 guidance
Tuesday, 15 Dec 2015 06:30am EST 

Magellan Health Inc:Expects FY 2016 net revenue in the range of $4.28 billion to $4.52 billion.Expects FY 2016 net income in the range of $51 million to $70 million, which translates into diluted earnings per share (EPS) in the range of $2.06 to $2.83.Expects FY 2016 adjusted net income to be in the range of $75.5 million to $94.5 million, which equates to adjusted EPS in the range of $3.06 to $3.83.  Full Article

Magellan Health Inc updates FY 2015 EPS guidance
Monday, 27 Jul 2015 06:30am EDT 

Magellan Health Inc:Updates its FY 2015 EPS guidance to reflect impact of recent share repurchase activity.Expects FY 2015 fully diluted EPS to be between $1.69 and $2.28, and fully diluted adjusted EPS between $3.45 and $3.90.  Full Article

Magellan Health announces new business unit alignment
Thursday, 4 Jun 2015 06:30am EDT 

Magellan Health:Announces new business unit alignment and business CEO transitions.Says bob field, CEO of MAGELLAN rx management, has decided to retire at the end of 2015.Sam Srivastava, CEO of MAGELLAN healthcare, will lead nia magellan's integration and the subsequent combined business unit.MAGELLAN complete care and MAGELLAN rx management - the company will be organized into two primary business units going forward.Says effective July 1, nia MAGELLAN will be integrated into MAGELLAN healthcare.Magellan health -company will be organized into two primary business units going forward - MAGELLAN healthcare and MAGELLAN rx management.Named mostafa kamal, current general manager and senior vice president of MAGELLAN rx management's specialty division, as new CEO.Says tina blasi, CEO of nia MAGELLAN, will remain at MAGELLAN until the end of June.  Full Article

Magellan Health raises FY 2015 guidance
Thursday, 30 Apr 2015 06:30am EDT 

Magellan Health Inc:Expects FY 2015 revenue guidance of $4.45 - $4.69 bln.Expects FY 2015 net income guidance of $45 - $61 mln.Expects FY 2015 adjusted net income to range from $92 - $104 mln.Expects FY 2015 fully diluted EPS to be $1.67 to $2.26.Expects FY 2015 fully diluted adjusted EPS of $3.41 - $3.85.FY 2015 revenue of $4.46 bln, net income of $62.46 mln and EPS of $2.40 - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Magellan Health reports Q4 earnings per share $1.50

* Magellan Health reports fourth quarter 2016 and full year financial results